David Ewing Duncan is an award-winning, best-selling author of nine books published in 21 languages. David is CEO and Curator of Arc Fusion, and a Health Strategist in Residence for IDEO. He is a columnist for the Daily Beast and the chief correspondent for NPR Talk’s Biotech Nation. David writes for The New York Times, Atlantic, Fortune, Wired, National Geographic, Discover, and Outside, among others. He is a former commentator for NPR’s Morning Edition and a special correspondent and producer for ABC’s Nightline and 20/20, a former producer for Discovery Channel, and a correspondent for NOVA’s ScienceNow!. His latest book is When I’m 164: The new science of radical life extension, and what happens if it succeeds (TED books). He also wrote Experimental Man: What One Man’s Body Reveals about His Future, Your Health, and Our Toxic World (Wiley). He is the founding director of the Center of Life Science Policy at UC Berkeley, and is on the faculty at Singularity University. David is finishing his first novel, a biomedical thriller. David’s work has won numerous awards, including Magazine Story of the Year from AAAS, and has been nominated for National Magazine Awards. He has served on an advisory committees of the National Academies of Sciences. David lives in San Francisco and is a member of the San Francisco Writers’ Grotto.